Novel assays of multiple lymphocyte functions in whole blood measure: New mechanisms of action of mycophenolate mofetil in vivo

Transplant Immunology

Volumn 10, Issue 1, 2002, Pages 1-14

  Barten, Markus J ^a   Van Gelder, Teun ^a   Gummert, Jan F ^a   Shorthouse, Randi ^a   Morris, Randall E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lymphocyte functions; Mechanisms of action; Mycophenolate mofetil; Whole blood

Indexed keywords

CALCIUM; CD134 ANTIGEN; CD71 ANTIGEN; DNA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MITOGENIC AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMIDINE; TRITIUM; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DNA CONTENT; DOSE RESPONSE; DRUG MECHANISM; FLOW CYTOMETRY; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; STIMULATION; T LYMPHOCYTE; ANIMAL; DRUG EFFECT; IMMUNOLOGY; LEWIS RAT; LYMPHOCYTE; METABOLISM;

ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MALE; MYCOPHENOLIC ACID; RATS; RATS, INBRED LEW; SUPPORT, NON-U.S. GOV'T; THYMIDINE; ANIMALS;

EID: 0036023133     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(01)00041-7     Document Type: Article

References (51)

1. Pharmacokinetics of mycophenolate mofetil (RS61443): A short review
2. The inhibition of nucleic acid synthesis by mycophenolic acid
3. Nuclear magnetic resonance and molecular modeling study on mycophenolic acid: Implications for binding to inosine monophosphate dehydrogenase
4. Mechanism of action of mycophenolate mofetil
5. Comparison of the in vitro and biophysical effects of cyclosporine A, FK-506, and mycophenolic acid on human peripheral blood lymphocytes
6. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin
7. Mycophenolic acid-induced GTP depletion also affects ATP and pyrimidine synthesis in mitogen-stimulated primary human T lymphocytes
8. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)
9. Pharmacodynamics of the inhibition of GTP synthesis in vivo by mycophenolic acid
10. Pharmacodynamics of immunosuppressive drugs
11. Novel method for the measurement of cytokine production by a one-stage procedure
12. Single- and multiple-dose pharmacokinetics and pharmacodynamics of leflunomide's active metabolite A77 1726 in normal Lewis rats
13. In vitro and in vivo effects of leflunomide, brequinar, and cyclosporine on pyrimidine biosynthesis
14. Differential effects of corticosteroids on rat peripheral blood T-lymphocyte mitogenesis in vivo and in vitro
15. A new method for measuring lymphoproliferation at the single-cell level in whole blood cultures by flow cytometry
16. Pharmacodynamics of immunosuppression by mycophenolic acid: Inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics
17. Pharmacodynamics of mycophenolic acid in heart allograft recipients: Correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology
18. Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: Inhibition by immunosuppressive drugs in vitro
19. Cyclin: A nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells
20. The IL-2/IL-2 receptor system: A current overview
21. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes: A molecule related to nerve growth factor receptor
22. Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft vs. host disease
23. Selenium and vitamin E deficiency impair transferrin receptor internalization but not IL-2, IL-2 receptor, or transferrin receptor expression
24. Cell adhesion in the immune system
25. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T-cell receptor-mediated activation of resting T cells
26. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: Role of deoxyguanosine nucleotide depletion
27. + human lymphocytes
28. Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T-cell activation molecule expression in human mixed lymphocyte cultures
29. Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endothelial cells and to some substrates
30. Mycophenolic acid does not inhibit protein glycosylation in T lymphocytes
31. Effect of anesthesia on a whole blood lymphocyte proliferation assay in the rat
32. Comparison of whole blood and purified canine lymphocytes in a lymphocyte-stimulation microassay
33. Sequential monitoring of peripheral blood lymphocyte subsets in rats
34. A high-performance liquid chromatographic assay with a simple extraction procedure for sensitive quantification of mycophenolic acid in rat and human plasma
35. T cell adhesion to intercellular adhesion molecule-1 (ICAM-1) is controlled by cell spreading and the activation of integrin LFA-1
36. The use of therapeutic drug monitoring to optimize immunosuppressive therapy
37. Pharmacodynamic monitoring of immunosuppressive drugs
38. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: Tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide
39. Effect of mycophenolate mofetil (RS-61443) on cytokine production: Inhibition of superantigen-induced cytokines
40. Guanine nucleotide depletion and toxicity in mouse T lymphoma (S-49) cells
41. Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors
42. Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans
43. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis
44. GTP dependence of the transduction of mitogenic signals through the T3 complex in T lymphocytes indicates the involvement of a G-protein
45. Ins and outs of LFA-1
46. The critical glycosylation site of human transferrin receptor contains a high-mannose oligosaccharide
47. Adhesion receptors of the immune system
48. Novel mechanisms of brequinar sodium immunosuppression on T cell activation
49. Pharmacodynamic monitoring of mycophenolic acid in rabbit heterotopic heart transplant model
50. Mycophenolate mofetil: A report of the consensus panel
51. Pharmacodynamics (PD) of mycophenolate mofetil (MMF) after heart transplantation identify new mechanism of action and correlate with severity of rejection